Anti-PD-L1 (Atezolizumab), Humanized Antibody

Anti-PD-L1 (Atezolizumab), Humanized Antibodyis available at Gentaur for Next week Delivery.

Description: This research-grade biosimilar is a fully-humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). PD-L1 is an immune inhibitory receptor ligand that is expressed by T and B lymphocytes, as well as various types of tumor cells to escape immune surveillance. The antibody blocks the interaction of PD-L1 with PD-1 and induces anti-tumor immune reactivation.

Immunogen Sequence:Human programmed cell death 1 ligand 1 (PD-L1)

Target Alternative Name:CD274, Programmed Cell Death 1 Ligand 1, B7H1

Species Reactivities:Human

Tag Line:Monoclonal human IgG1 antibody against human PD-L1

Formulation:Supplied in phosphate buffered saline, pH 7.2

Purification: /

Application:/

Positive Control:/

Application And Usages:/

Handling:The antibody solution should be gently mixed before use